Arana Senior Management
 |
 |
 |
 |
David Fuller MBBS, B.Pharm(Hons) Chief Medical Officer David Fuller joined Arana in October 2007. David is dually qualified in medicine and pharmacy with more than 20 years international experience in clinical development and commercialisation of new medicines. He has previously worked at Genzyme, Orphan Medical and CeNeS in a number of senior product development roles. |
 |
Phil Jennings BSc, BVSc (Hons), PhD, FTSE Chief Scientific Officer In addition to having over 25 years of experience in science and science management, Phil also brings a depth of practical experience in patenting, intellectual property, biological and molecular science commercialisation, and the resolution of commercial/licensing disputes. Author of a number of pioneering papers in biotechnology, Phil is also an inventor of important granted patents and patent applications (Gene Shears, Betabiotic and Arana). Prior to joining Arana, Phil was a Chief Research Scientist, Corporate Fellow and a Chief of Division at the CSIRO. |
 |
Steffen Nock PhD Acting CEO; President, US Operations Steffen Nock joined Arana in April 2005. He is the former President of Absalus Inc., having previously participated in the foundation of Zyomyx, a biotechnology company in Hayward, CA, exploiting antibody-based proteomics technologies. Prior to this, Steffen held scientific research positions at Stanford University, USA, and in Germany. He was one of four founders of Absalus that was acquired by Arana in April, 2005, when he became President of the company’s US operation. |